The findings of trials using intismeran, an mRNA-based individualised vaccine, was published at the 2026 annual meeting of ...

A technological platform developed by Brazilian researchers could revolutionize the treatment of skin diseases such as ...

Eli Lilly has expanded its genetic medicines pipeline and capabilities, agreeing to partner with Ascidian Therapeutics to develop RNA exon editors intended to treat inherited kidney diseases, through ...

Doctors and researchers told a US Senate subcommittee on Tuesday that there may be plausible links between COVID-19 ...

WHO reports 321 confirmed cases, 116 suspected infections and 48 deaths. Soumya Swaminathan says India should stay alert but ...

The University of Port Harcourt, in collaboration with the African Policy and Research Consortium, hosted a two-day high-level academic gathering on May 21 – 22, 2026 with a focus on repositioning ...

A consistent biological barrier that stops the immune system from making the antibodies most needed to protect the nose and ...

Recent research showed that an artificially constructed self-replicating RNA system modeling primitive life at the origin of ...

The results of a phase 2 trial, presented at ASCO 2026, suggest that a combination of a personalized vaccine, known as ...

Worldwide Healthcare Trust PLC - Annual Financial Report PR Newswire LONDON, United Kingdom, June 05 4 June 2026 Worldwide ...

Matt Mande and Gregory C. Allen provide a detailed overview Maven Smart System, the AI-powered software platform that has ...